UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended: September 30, 20172018
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number: 001-31990
TEL-INSTRUMENT ELECTRONICS CORP.
(Exact name of registrant as specified in its charter)
New Jersey | 22-1441806 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
One Branca Road East Rutherford, NJ 07073 |
(Address of principal executive offices) |
(201) 933-1600 |
(Registrant’s telephone number, including area code) |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months, and (2) has been subject to such filing requirements for the past 90 days. Yes ý☒ No ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.files). Yes ý☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ |
Non-accelerated filer | ☐ (Do not check if a smaller reporting company) | Smaller reporting company | ☒ |
Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ý
As of November 13, 2017,12, 2018, there were 3,255,887 shares outstanding of the registrant’s common stock.
TEL-INSTRUMENT ELECTRONICS CORP.
PART I – FINANCIAL INFORMATION | ||
Page | ||
Item 1. | 3 | |
Item 2. | ||
Item 3. | ||
Item 4. | ||
| PART II – OTHER INFORMATION | ||
Item 1. | ||
Item 1A. | ||
Item 2. | ||
Item 3. | ||
Item 4. | ||
Item 5. | ||
Item 6. | ||
PART I – FINANCIAL INFORMATION
CONDENSED CONSOLIDATED BALANCE SHEETS
September 30, 2017 | March 31, 2017 | |||||||
| (unaudited) | ||||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 130,235 | $ | 287,873 | ||||
| Accounts receivable, net | 1,067,277 | 1,556,382 | ||||||
| Inventories, net | 4,456,377 | 4,208,179 | ||||||
| Prepaid expenses and other current assets | 77,282 | 188,578 | ||||||
| Total current assets | 5,731,171 | 6,241,012 | ||||||
| Equipment and leasehold improvements, net | 176,717 | 161,427 | ||||||
| Other long-term assets | 33,509 | 33,509 | ||||||
| Total assets | 5,941,397 | 6,435,948 | ||||||
| LIABILITIES & STOCKHOLDERS’ (DEFICIT) EQUITY | ||||||||
| Current liabilities: | ||||||||
| Current portion of long-term debt | 77,802 | 291,991 | ||||||
| Line of credit | 1,000,000 | 200,000 | ||||||
| Capital lease obligations – current portion | 6,564 | 6,268 | ||||||
| Accounts payable and accrued liabilities | 2,357,566 | 2,072,955 | ||||||
| Federal and state taxes payable | - | 4,105 | ||||||
| Deferred revenues – current portion | 45,358 | 123,720 | ||||||
| Accrued legal damages | 4,900,000 | 2,800,000 | ||||||
| Accrued payroll, vacation pay and payroll taxes | 417,016 | 527,413 | ||||||
| Total current liabilities | 8,804,306 | 6,026,452 | ||||||
| Capital lease obligations – long-term | 10,402 | 13,760 | ||||||
| Long-term debt | - | 2,124 | ||||||
| Deferred revenues – long-term | 366,915 | 352,973 | ||||||
| Warrant liability | 5,000 | 95,000 | ||||||
| Total liabilities | 9,186,623 | 6,490,309 | ||||||
| Commitments | ||||||||
| Stockholders’ (deficit) equity: | ||||||||
Common stock, 4,000,000 shares authorized, par value $0.10 per share, 3,255,887 shares issued and outstanding, respectively | 325,586 | 325,586 | ||||||
| Additional paid-in capital | 8,123,184 | 8,107,369 | ||||||
| Accumulated deficit | (11,693,996 | ) | (8,487,316 | ) | ||||
| Total stockholders’ (deficit) equity | (3,245,226 | ) | (54,361 | ) | ||||
| Total liabilities and stockholders’ (deficit) equity | $ | 5,941,397 | $ | 6,435,948 | ||||
September 30, 2018 | March 31, 2018 | |||||||
(unaudited) | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 278,443 | $ | 307,812 | ||||
Accounts receivable, net | 769,553 | 1,095,049 | ||||||
Inventories, net | 3,762,164 | 4,269,934 | ||||||
Restricted cash to support appeal bond | 2,002,873 | 2,000,866 | ||||||
Prepaid expenses and other current assets | 130,835 | 147,746 | ||||||
Total current assets | 6,943,868 | 7,821,407 | ||||||
Equipment and leasehold improvements, net | 142,917 | 180,763 | ||||||
Deferred tax asset, net | 63,500 | 63,500 | ||||||
Other long-term assets | 35,109 | 35,109 | ||||||
Total assets | 7,185,394 | 8,100,779 | ||||||
LIABILITIES & STOCKHOLDERS’ DEFICIT | ||||||||
Current liabilities: | ||||||||
Current portion of long-term debt | - | 2,124 | ||||||
Line of credit | 840,000 | 1,000,000 | ||||||
Capital lease obligations – current portion | 7,200 | 6,875 | ||||||
Accounts payable and accrued liabilities | 2,355,269 | 2,580,383 | ||||||
Deferred revenues – current portion | 344,164 | 60,051 | ||||||
Accrued legal damages | 5,144,644 | 5,059,990 | ||||||
Accrued payroll, vacation pay and payroll taxes | 363,588 | 447,863 | ||||||
Total current liabilities | 9,054,865 | 9,157,286 | ||||||
Capital lease obligations – long-term | 3,202 | 6,885 | ||||||
Deferred revenues – long-term | 296,526 | 337,676 | ||||||
Total liabilities | 9,354,593 | 9,501,847 | ||||||
Commitments and contingencies | ||||||||
Stockholders’ deficit: | ||||||||
Preferred stock, 1,000,000 shares authorized, par value $0.10 per share, 500,000 shares 8% Cumulative Series A Convertible Preferred issued and Outstanding | 3,155,998 | 3,035,998 | ||||||
Common stock, 4,000,000 shares authorized, par value $0.10 per share, 3,255,887 shares issued and outstanding, respectively | 325,586 | 325,586 | ||||||
Paid-in capital in excess of par value, common stock | 8,096,327 | 8,046,975 | ||||||
Accumulated deficit | (13,747,110 | ) | (12,809,627 | ) | ||||
Total stockholders’ deficit | (2,169,199 | ) | (1,401,068 | ) | ||||
Total liabilities and stockholders’ deficit | $ | 7,185,394 | $ | 8,100,779 | ||||
See accompanying notes to condensed consolidated financial statements.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
| Three Months Ended | Six Months Ended | |||||||||||||||
| September 30, 2017 | September 30, 2016 | September 30, 2017 | September 30, 2016 | |||||||||||||
| Net sales | $ | 1,787,165 | $ | 5,076,029 | $ | 5,329,242 | $ | 10,418,398 | ||||||||
| Cost of sales | 1,387,295 | 3,250,441 | 3,688,082 | 6,716,157 | ||||||||||||
| Gross margin | 399,870 | 1,825,588 | 1,641,160 | 3,702,241 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Selling, general and administrative | 626,395 | 687,013 | 1,332,681 | 1,460,042 | ||||||||||||
| Litigation expenses | 43,333 | 188,125 | 425,845 | 326,840 | ||||||||||||
| Legal damages | 2,100,000 | - | 2,100,000 | - | ||||||||||||
| Engineering, research and development | 529,667 | 583,771 | 1,144,940 | 1,168,648 | ||||||||||||
| Total operating expenses | 3,299,395 | 1,458,909 | 5,003,466 | 2,955,530 | ||||||||||||
| (Loss) income from operations | (2,899,525 | ) | 366,679 | (3,362,306 | ) | 746,711 | ||||||||||
| Other income (expense): | ||||||||||||||||
| Proceeds from life insurance | - | - | 92,678 | - | ||||||||||||
| Amortization of deferred financing costs | (1,357 | ) | (1,357 | ) | (2,714 | ) | (2,713 | ) | ||||||||
| Change in fair value of common stock warrants | (5,000 | ) | �� | 34,000 | 90,000 | 251,203 | ||||||||||
| Interest expense | (14,707 | ) | (17,507 | ) | (24,338 | ) | (35,333 | ) | ||||||||
| Total other (expense) income | (21,064 | ) | 15,136 | 155,626 | 213,157 | |||||||||||
| (Loss) income before income taxes | (2,920,589 | ) | 381,815 | (3,206,680 | ) | 959,868 | ||||||||||
| Income tax expense | - | 109,760 | - | 277,504 | ||||||||||||
| Net (loss) income | $ | (2,920,589 | ) | $ | 272,055 | $ | (3,206,680 | ) | $ | 682,364 | ||||||
| Basic (loss) income per common share | $ | (0.90 | ) | $ | 0.08 | $ | (0.98 | ) | $ | 0.21 | ||||||
| Diluted (loss) income per common share | $ | (0.90 | ) | $ | 0.07 | $ | (0.98 | ) | $ | 0.20 | ||||||
| Weighted average shares outstanding: | ||||||||||||||||
| Basic | 3,255,887 | 3,255,887 | 3,255,887 | 3,255,887 | ||||||||||||
| Diluted | 3,255,887 | 3,266,133 | 3,255,887 | 3,267,192 | ||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||
September 30, 2018 | September 30, 2017 | September 30, 2018 | September 30, 2017 | |||||||||||||
Net sales | $ | 2,222,941 | $ | 1,787,165 | $ | 4,037,155 | $ | 5,329,242 | ||||||||
Cost of sales | 1,223,728 | 1,387,295 | 2,556,629 | 3,688,082 | ||||||||||||
Gross margin | 999,213 | 399,870 | 1,480,526 | 1,641,160 | ||||||||||||
Operating expenses: | ||||||||||||||||
Selling, general and administrative | 555,411 | 626,395 | 1,121,936 | 1,332,681 | ||||||||||||
Litigation expenses | 35,848 | 43,333 | 75,119 | 425,845 | ||||||||||||
Legal damages | - | 2,100,000 | - | 2,100,000 | ||||||||||||
Engineering, research and development | 503,380 | 529,667 | 1,020,703 | 1,144,940 | ||||||||||||
Total operating expenses | 1,094,639 | 3,299,395 | 2,217,758 | 5,003,466 | ||||||||||||
Loss from operations | (95,426 | ) | (2,899,525 | ) | (737,232 | ) | (3,362,306 | ) | ||||||||
Other income (expense): | ||||||||||||||||
Interest income | 1,009 | - | 2,007 | - | ||||||||||||
Proceeds from life insurance | - | - | - | 92,678 | ||||||||||||
Amortization of deferred financing costs | - | (1,357 | ) | - | (2,714 | ) | ||||||||||
Change in fair value of common stock warrants | - | (5,000 | ) | - | 90,000 | |||||||||||
Interest expense - judgement | (72,003 | ) | (143,223 | ) | - | |||||||||||
Interest expense | (24,990 | ) | (14,707 | ) | (59,035 | ) | (24,338 | ) | ||||||||
Total other (expense) income | (95,984 | ) | (21,064 | ) | (200,251 | ) | 155,626 | |||||||||
Loss income before income taxes | (191,410 | ) | (2,920,589 | ) | (937,483 | ) | (3,206,680 | ) | ||||||||
Income tax expense | - | - | - | - | ||||||||||||
Net loss | $ | (191,410 | ) | $ | (2,920,589 | ) | $ | (937,483 | ) | $ | (3,206,680 | ) | ||||
Preferred dividends | 60,000 | - | 120,000 | - | ||||||||||||
Net loss attributable to common shareholders | $ | (251,410 | ) | $ | (2,920,589 | ) | $ | (1,057,483 | ) | $ | (3,206,680 | ) | ||||
Basic loss per common share | $ | (0.08 | ) | $ | (0.90 | ) | $ | (0.32 | ) | $ | (0.98 | ) | ||||
Diluted loss per common share | $ | (0.08 | ) | $ | (0.90 | ) | $ | (0.32 | ) | $ | (0.98 | ) | ||||
Weighted average shares outstanding: | ||||||||||||||||
Basic | 3,255,887 | 3,255,887 | 3,255,887 | 3,255,887 | ||||||||||||
Diluted | 3,255,887 | 3,255,887 | 3,255,887 | 3,255,887 | ||||||||||||
See accompanying notes to condensed consolidated financial statements.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
| Six Months Ended | ||||||||
| September 30, 2017 | September 30, 2016 | |||||||
| Cash flows from operating activities: | ||||||||
| Net (loss) income | $ | (3,206,680 | ) | $ | 682,364 | |||
Adjustments to reconcile net (loss) income to net cash used in operating activities: | ||||||||
| Deferred income taxes | - | 277,504 | ||||||
| Depreciation and amortization | 38,112 | 71,390 | ||||||
| Provision for inventory obsolescence | 25,000 | 15,000 | ||||||
| Amortization of deferred financing costs | 2,714 | 2,713 | ||||||
| Change in fair value of common stock warrant | (90,000 | ) | (251,203 | ) | ||||
| Non-cash stock-based compensation | 15,815 | 16,358 | ||||||
| Changes in assets and liabilities: | ||||||||
| Decrease (increase) in accounts receivable | 489,105 | (406,895 | ) | |||||
| (Increase) decrease in inventories | (273,198 | ) | 988,244 | |||||
| Decrease in prepaid expenses & other assets | 108,582 | 42,789 | ||||||
| Increase (decrease) in accounts payable and other accrued expenses | 284,611 | (678,052 | ) | |||||
| Decrease in federal and state taxes | (4,105 | ) | (53,623 | ) | ||||
| Decrease in accrued payroll, vacation pay & withholdings | (110,397 | ) | (257,011 | ) | ||||
| (Decrease) increase in deferred revenues | (64,420 | ) | 405,073 | |||||
| Increase in accrued legal damages | 2,100,000 | - | ||||||
| Decrease in other long-term liabilities | - | (7,800 | ) | |||||
| Net cash (used in) provided by operating activities | (684,861 | ) | 846,851 | |||||
| Cash flows from investing activities: | ||||||||
| Purchases of equipment | (53,402 | ) | (30,303 | ) | ||||
| Net cash used in investing activities | (53,402 | ) | (30,303 | ) | ||||
| Cash flows from financing activities: | ||||||||
| Proceeds from line of credit | 800,000 | - | ||||||
| Payment of warrant liability | - | (720,000 | ) | |||||
| Repayment of long-term debt | (216,313 | ) | (205,838 | ) | ||||
| Repayment of subordinated notes - related parties | - | �� | (25,000 | ) | ||||
| Repayment of capitalized lease obligations | (3,062 | ) | (7,809 | ) | ||||
| Net cash provided by (used in) financing activities | 580,625 | (958,647 | ) | |||||
| Net decrease in cash and cash equivalents | (157,638 | ) | (142,099 | ) | ||||
| Cash and cash equivalents at beginning of period | 287,873 | 972,633 | ||||||
| Cash and cash equivalents at end of period | $ | 130,235 | $ | 830,534 | ||||
| Supplemental cash flow information: | ||||||||
| Taxes paid | $ | 5,000 | $ | 50,000 | ||||
| Interest paid | $ | 36,477 | $ | 32,642 | ||||
Six Months Ended | ||||||||
September 30, 2018 | September 30, 2017 | |||||||
Cash flows from operating activities: | ||||||||
Net loss | $ | (937,483 | ) | $ | (3,206,680 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Deferred income taxes | - | - | ||||||
Depreciation and amortization | 37,846 | 38,112 | ||||||
Provision for inventory obsolescence | 45,000 | 25,000 | ||||||
Amortization of deferred financing costs | - | 2,714 | ||||||
Change in fair value of common stock warrant | - | (90,000 | ) | |||||
Non-cash stock-based compensation | 13,177 | 15,815 | ||||||
Changes in assets and liabilities: | ||||||||
Decrease in accounts receivable | 325,496 | 489,105 | ||||||
Decrease (increase) in inventories | 462,770 | (273,198 | ) | |||||
Decrease in prepaid expenses & other assets | 16,911 | 108,582 | ||||||
Increase in restricted cash for appeal bond | (2,007 | ) | - | |||||
(Decrease) increase in accounts payable and other accrued expenses | (225,114 | ) | 284,611 | |||||
Decrease in federal and state taxes | - | (4,105 | ) | |||||
Decrease in accrued payroll, vacation pay & withholdings | (84,275 | ) | (110,397 | ) | ||||
Increase (decrease) increase in deferred revenues | 242,963 | (64,420 | ) | |||||
Increase in accrued legal damages | 84,654 | 2,100,000 | ||||||
Net cash used in operating activities | (20,062 | ) | (684,861 | ) | ||||
Cash flows from investing activities: | ||||||||
Purchases of equipment | - | (53,402 | ) | |||||
Net cash used in investing activities | - | (53,402 | ) | |||||
Cash flows from financing activities: | ||||||||
Proceeds from line of credit | - | 800,000 | ||||||
Repayment of line of credit | (160,000 | ) | - | |||||
Repayment of long-term debt | (2,124 | ) | (216,313 | ) | ||||
Proceeds from short-swing profits from an investor | 156,175 | - | ||||||
Repayment of capitalized lease obligations | (3,358 | ) | (3,062 | ) | ||||
Net cash (used in) provided by financing activities | (9,307 | ) | 580,625 | |||||
Net decrease in cash and cash equivalents | (29,369 | ) | (157,638 | ) | ||||
Cash and cash equivalents at beginning of period | 307,812 | 287,873 | ||||||
Cash and cash equivalents at end of period | $ | 278,443 | $ | 130,235 | ||||
Supplemental cash flow information: | ||||||||
Taxes paid | $ | - | $ | 5,000 | ||||
Interest paid | $ | 28,278 | $ | 36,477 | ||||
See accompanying notes to condensed consolidated financial statements.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1 – Basis of Presentation
In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of Tel-Instrument Electronics Corp. (the “Company” or “TIC” or “Tel”) as of September 30, 2017,2018, the results of operations for the three and six months ended September 30, 20172018 and September 30, 2016,2017, and statements of cash flows for the three and six months ended September 30, 20172018 and September 30, 2016.2017. These results are not necessarily indicative of the results to be expected for the full year. The financial statements have been prepared in accordance with the requirements of Form 10-Q and consequently do not include disclosures normally made in an Annual Report on Form 10-K. The March 31, 20172018 balance sheet included herein was derived from the audited financial statements included in the Company’s Annual Report on Form 10-K as of that date. Accordingly, the financial statements included herein should be reviewed in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2017,2018, as filed with the United States Securities and Exchange Commission (the “SEC”) on July 14, 201716, 2018 (the “Annual Report).
Note 2 -– Liquidity and Going Concern
These condensed consolidated financial statements have been prepared in conformity with GAAP, which contemplates continuation of the Company as a going concern. As reflected in the accompanying financial statements, for the year ended March 31, 2018, the Company incurred a net loss of $4,322,311 and a loss of $937,483 for the six months ended September 30, 2018. As discussed in Note 14 to the Notes to the Condensed Consolidated Financial Statements, the Company has recorded totalestimated damages to date of $4,900,000$5,144,644, including interest and additional fees, as a result of the jury verdict associated with the Aeroflex litigation as well as the court’s decision on punitive damages. litigation. The Company has filed for an appeal.
The jury found no misappropriation of Aeroflex trade secrets but it did rule that the Company tortiously interfered with a prospective business opportunity and awarded damages. The jury also ruled that Tel tortiously interfered with Aeroflex’s non-disclosure agreements with two former Aeroflex employees. The jury also found that the former Aeroflex employees breached their non-disclosure agreements with Aeroflex. The courtCourt conducted further hearings on the Company’s post-trial motions which sought to reduce the damages award of $2.8 million, as well as the punitive damages claim. The courtCourt denied the Company’s motions and awarded Aeroflex an additional $2.1 million of punitive damages. The Company has filed motions in January 2018 for the Court to reconsider the amount of damages which bringson the total Tel damages awarded in this case to approximately $4.9 million. No judgment has yet been entered by the court, and we have filed a motion with the courtgrounds that these changesthey are duplicative and not supported by Kansas Law.
The Company believes it has sufficient financing in place to fund its plans for the next twelve months due in part to recent large orders it has received that should return the Company to profitability. The Company’s line of credit agreement expires on May 31, 2019. On October 5, 2018, the Company entered into a definitive subscription agreement with an accredited investor, pursuant to which the investor purchased an aggregate of 166,667 shares of the Company’s Series B Preferred Stock (the “Series B Preferred”) for $1 million. The Company intends to use such proceeds for working capital purposes. We have no other firm commitments from any party to provide additional working capital and there is no assurance that any funding will be available as required, or if available, that its terms will be favorable or acceptable to the Company. The pending judgment raises substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued.
The financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities and commitments in the normal course of business. The ability of the Company to continue as a going concern is dependent upon its ability to raise additional capital to support the appeal process or pay any final damages amount and achieve profitable operations. In November 2017, the Company signed a subscription agreement in which the Company received $3 million for Series A Convertible Preferred Stock (See Note 16 to the Notes to the Condensed Financial Statements). These funds will be used to finance an appeal and provide funds for operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
Note 3 – Summary of Significant Accounting Policies
During the six months ended September 30, 2017,2018, there have been no material changes in the Company’s significant accounting policies to those previously disclosed in the Annual Report.
TEL-INSTRUMENT ELECTRONICS CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 4 – Accounts Receivable, net
The following table sets forth the components of accounts receivable:
September 30, 2017 | March 31, 2017 | |||||||
| Government | $ | 660,135 | $ | 1,392,482 | ||||
| Commercial | 414,642 | 171,400 | ||||||
| Less: Allowance for doubtful accounts | (7,500 | ) | (7,500 | ) | ||||
| $ | 1,067,277 | $ | 1,556,382 | |||||
Note 56 – Inventories, net
Inventories consist of:
September 30, 2017 | March 31, 2017 | |||||||
| Purchased parts | $ | 3,682,890 | $ | 3,197,378 | ||||
| Work-in-process | 1,040,989 | 1,272,235 | ||||||
| Finished goods | 87,498 | 68,566 | ||||||
| Less: Inventory reserve | (355,000 | ) | (330,000 | ) | ||||
| $ | 4,456,377 | $ | 4,208,179 | |||||
September 30, 2018 | March 31, 2018 | |||||||
Purchased parts | $ | 2,956,459 | $ | 3,571,874 | ||||
Work-in-process | 1,254,607 | 1,051,725 | ||||||
Finished goods | 16,098 | 66,335 | ||||||
Less: Inventory reserve | (465,000 | ) | (420,000 | ) | ||||
| $ | 3,762,164 | $ | 4,269,934 | |||||
Note 67 – Net Income (Loss)Loss per Share
Net income (loss) per share has been computed according to Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC 260”), “Earnings per Share,” which requires a dual presentation of basic and diluted income (loss) per share (“EPS”). Basic EPS represents net income (loss) divided by the weighted average number of common shares outstanding during a reporting period. Diluted EPS reflects the potential dilution that could occur if securities, including warrants and options, were converted into common stock. The dilutive effect of outstanding warrants and options is reflected in earnings per share by use of the treasury stock method. In applying the treasury stock method for stock-based compensation arrangements, the assumed proceeds are computed as the sum of the amount the employee must pay upon exercise and the amounts of average unrecognized compensation costs attributed to future services.
| Three Months Ended | Three Months Ended | |||||||
| September 30, 2017 | September 30, 2016 | |||||||
| Basic net (loss) income per share computation: | ||||||||
| Net (loss) income | $ | (2,920,589 | ) | $ | 272,055 | |||
| Weighted-average common shares outstanding | 3,255,887 | 3,255,887 | ||||||
| Basic net (loss) income per share | $ | (0.90 | ) | $ | 0.08 | |||
| Diluted net (loss) income per share computation | ||||||||
| Net (loss) income | $ | (2,920,589 | ) | $ | 272,055 | |||
| Add: Change in fair value of warrants | - | 34,000 | ||||||
| Diluted (loss) income | $ | (2,920,589 | ) | 238,055 | ||||
| Weighted-average common shares outstanding | 3,255,887 | 3,255,887 | ||||||
Incremental shares attributable to the assumed exercise of outstanding stock options and warrants | - | 10,246 | ||||||
| Total adjusted weighted-average shares | 3,255,887 | �� | 3,266,133 | |||||
| Diluted net (loss) income per share | $ | (0.90 | ) | $ | 0.07 | |||
Three Months Ended | Three Months Ended | |||||||
September 30, 2018 | September 30, 2017 | |||||||
Basic net loss per share computation: | ||||||||
Net loss | $ | (191,410 | ) | $ | (2,920,589 | ) | ||
Add: Preferred dividends | (60,000 | ) | - | |||||
Net loss attributable to common shareholders | (251,410 | ) | (2,920,589 | ) | ||||
Weighted-average common shares outstanding | 3,255,887 | 3,255,887 | ||||||
Basic net loss per share | $ | (0.08 | ) | $ | (0.90 | ) | ||
Diluted net loss per share computation | ||||||||
Net loss income | $ | (191,410 | ) | $ | (2,920,589 | ) | ||
Add: Preferred dividends | (60,000 | ) | - | |||||
Diluted loss income | $ | (251,410 | ) | (2,920,589 | ) | |||
Weighted-average common shares outstanding | 3,255,887 | 3,255,887 | ||||||
Incremental shares attributable to the assumed exercise of outstanding stock options and warrants | - | - | ||||||
Total adjusted weighted-average shares | 3,255,887 | 3,255,887 | ||||||
Diluted net loss per share | $ | (0.08 | ) | $ | (0.90 | ) | ||
TEL-INSTRUMENT ELECTRONICS CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 67 – Net Income (Loss)Loss per Share (continued)(Continued)
| Six Months Ended | Six Months Ended | |||||||
| September 30, 2017 | September 30, 2016 | |||||||
| Basic net income per share computation: | ||||||||
| Net (loss) income | $ | (3,206,680 | ) | $ | 682,364 | |||
| Weighted-average common shares outstanding | 3,255,887 | 3,255,887 | ||||||
| Basic net income per share | $ | (0.98 | ) | $ | 0.21 | |||
| Diluted net income per share computation | ||||||||
| Net income | $ | (3,206,680 | ) | $ | 682,364 | |||
| Change in fair value of warrants | - | 33,000 | ||||||
| Diluted income | $ | (3,206,680 | ) | 649,364 | ||||
| Weighted-average common shares outstanding | 3,255,887 | 3,255,887 | ||||||
Incremental shares attributable to the assumed exercise of outstanding stock options and warrants | - | 11,305 | ||||||
| Total adjusted weighted-average shares | 3,255,887 | 3,267,192 | ||||||
| Diluted net (loss) income per share | $ | (0.98 | ) | $ | 0.20 | |||
Six Months Ended | Six Months Ended | |||||||
September 30, 2018 | September 30, 2017 | |||||||
Basic net loss per share computation: | ||||||||
Net loss | $ | (937,483 | ) | $ | (3,206,680 | ) | ||
Add: Preferred dividends | (120,000 | ) | - | |||||
Net loss attributable to common shareholders | (1,057,483 | ) | (3,206,680 | ) | ||||
Weighted-average common shares outstanding | 3,255,887 | 3,255,887 | ||||||
Basic net income per share | $ | (0.32 | ) | $ | (0.98 | ) | ||
Diluted net loss per share computation | ||||||||
Net loss | $ | (937,483 | ) | $ | (3,206,680 | ) | ||
Add: Preferred dividends | (120,000 | ) | - | |||||
Diluted loss attributable to common shareholders | $ | (1,057,483 | ) | (3,206,680 | ) | |||
Weighted-average common shares outstanding | 3,255,887 | 3,255,887 | ||||||
Incremental shares attributable to the assumed exercise of outstanding stock options and warrants | - | - | ||||||
Total adjusted weighted-average shares | 3,255,887 | 3,255,887 | ||||||
Diluted net loss per share | $ | (0.32 | ) | $ | (0.98 | ) | ||
The following table summarizes securities that, if exercised, would have an anti-dilutive effect on earnings per share:
September 30, 2017 | September 30, 2016 | |||||||
| Stock options | 77,000 | 75,000 | ||||||
| Warrants | 50,000 | - | ||||||
| 127,000 | 75,000 | |||||||
September 30, 2018 | September 30, 2017 | |||||||
Convertible preferred stock | 1,070,222 | - | ||||||
Stock options | 42,500 | 77,000 | ||||||
Warrants | 50,000 | 50,000 | ||||||
| 1,162,722 | 127,000 | |||||||
Note 78 – Long-Term Debt
Term Loans with Bank of America
In July 2015, the Company entered into a term loan in the amount of $18,000 with Bank of America. The term loan iswas for three years, and maturesmatured in July 2018. Monthly payments are atwere $536 including interest at 4.5%. The term loan iswas collateralized by substantially all of the assets of the Company. At September 30, 20172018 and March 31, 2017,2018, the outstanding balances were $5,250$-0- and $8,305,$2,124, respectively. At September 30, 2017, $5,250This loan was classified as current.paid in full in July 2018.
TEL-INSTRUMENT ELECTRONICS CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 8 -9 – Line of Credit
On March 21, 2016, the Company entered into a line of credit agreement with Bank of America, which expired March 31, 2017. In March 2017, the line of credit was renewed and the expiration dateCompany extended until March 31, 2018. The new line providesprovided a revolving credit facility with borrowing capacity of up to $1,000,000. $1,000,000. There arewere no covenants or borrowing base calculations associated with this line of credit. Interest on any outstanding balances is payable monthly at an annual interest rate equalOn August 29, 2018, the Company entered a Loan Modification Agreement (the “Agreement”) with the bank. The Company had been working with the bank and had paid $100,000 to the LIBOR (London Interbank Offered Rates) Daily Floating plus 3.75 percentage points.bank to lower the outstanding balance to $900,000 at the signing of the Agreement. The Company’s interest rate was 4.985% at September 30, 2017. Agreement has the following provisions:
1) | The Company to make an additional principal payment of $50,000 by October 1, 2018. (The Company made this payment.) |
2) | Borrowing base calculation tied to accounts receivable and inventories. |
3) | The Agreement expires May 31, 2019. |
4) | Interest on any outstanding balances is payable monthly at an annual interest rate equal to the LIBOR (London Interbank Offered Rates) Daily Floating plus 3.75 percentage points. The Company’s interest rate was 5.915% at September 30, 2018. |
5) | The line is collateralized by substantially all of the assets of the Company. |
6) | The Company will make principal payments of $5,000 per month from September 30, 2018 through November 30, 2018 and principal payments of $10,000 per month from December 31, 2018 to May 31, 2019. |
7) | Beginning with the fiscal year ended March 31, 2019, the Company must maintain a debt service coverage ratio. |
During the six months ended September 30, 2017,2018, the Company borrowed $800,000 fromrepaid $160,000 against this line of credit. As of September 30, 20172018 and March 31, 2017,2018, the outstanding balances were $1,000,000$840,000 and $200,000,$1,000,000, respectively. As of September 30, 20172018 the remaining availability under this line is $-0-.
Note 10 – Segment Information
In accordance with FASB ASC 280, “Disclosures about Segments of an Enterprise and related information”, the Company determined it has two reportable segments - avionics government and avionics commercial. There are no inter-segment revenues.
The Company is organized primarily on the basis of its avionics products. The avionics government segment consists primarily of the design, manufacture, and sale of test equipment to the U.S. and foreign governments and militaries either directly or through distributors. The avionics commercial segment consists of design, manufacture, and sale of test equipment to domestic and foreign airlines, directly or through commercial distributors, and to general aviation repair and maintenance shops. The Company develops and designs test equipment for the avionics industry and as such, the Company’s products and designs cross segments.
Management evaluates the performance of its segments and allocates resources to them based on gross margin. The Company’s general and administrative costs and sales and marketing expenses, and engineering costs are not segment specific. As a result, all operating expenses are not managed on a segment basis. Net interest includes expenses on debt and income earned on cash balances, both maintained at the corporate level. Segment assets include accounts receivable and work-in-process inventory. Asset information, other than accounts receivable and work-in-process inventory, is not reported, since the Company does not produce such information internally. All long-lived assets are located in the U.S.
Three Months Ended September 30, 2017 | Avionics Government | Avionics Commercial | Avionics Total | Corporate Items | Total | |||||||||||||||
| Net sales | $ | 1,028,693 | $ | 758,472 | $ | 1,787,165 | $ | - | $ | 1,787,165 | ||||||||||
| Cost of sales | 660,589 | 726,706 | 1,387,295 | - | 1,387,295 | |||||||||||||||
| Gross margin | 368,104 | 31,766 | 399,870 | - | 399,870 | |||||||||||||||
| Engineering, research, and development | 529,667 | - | 529,667 | |||||||||||||||||
| Selling, general and administrative | 277,518 | 348,877 | 626,395 | |||||||||||||||||
| Litigation costs | 43,333 | 43,333 | ||||||||||||||||||
| Legal damages | 2,100,000 | 2,100,000 | ||||||||||||||||||
| Amortization of deferred financing costs | - | 1,357 | 1,357 | |||||||||||||||||
| Change in fair value of common stock warrants | - | 5,000 | 5,000 | |||||||||||||||||
| Proceeds from life insurance | - | - | ||||||||||||||||||
| Interest expense, net | - | 14,707 | 14,707 | |||||||||||||||||
| Total expenses | 807,185 | 2,513,274 | 3,320,459 | |||||||||||||||||
| Income (loss) before income taxes | $ | (407,315 | ) | $ | (2,513,274 | ) | $ | (2,920,589 | ) | |||||||||||
Three Months Ended September 30, 2018 | Avionics Government | Avionics Commercial | Avionics Total | Corporate Items | Total | |||||||||||||||
Net sales | $ | 1,284,099 | $ | 938,842 | $ | 2,222,941 | $ | - | $ | 2,222,941 | ||||||||||
Cost of sales | 714,590 | 509,138 | 1,223,728 | - | 1,223,728 | |||||||||||||||
Gross margin | 569,509 | 429,704 | 999,213 | - | 999,213 | |||||||||||||||
Engineering, research, and development | 503,380 | - | 503,380 | |||||||||||||||||
Selling, general and administrative | 194,179 | 361,232 | 555,411 | |||||||||||||||||
Litigation costs | 35,848 | 35,848 | ||||||||||||||||||
Interest income | - | (1,009 | ) | (1,009 | ) | |||||||||||||||
Interest expense - judgment | 72,003 | 72,003 | ||||||||||||||||||
Interest expense | - | 24,990 | 24,990 | |||||||||||||||||
Total expenses | 697,559 | 493,064 | 1,190,623 | |||||||||||||||||
Income (loss) before income taxes | $ | 301,654 | $ | (493,064 | ) | $ | (191,410 | ) | ||||||||||||
TEL-INSTRUMENT ELECTRONICS CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 10 – Segment Information (continued)
Three Months Ended September 30, 2016 | Avionics Government | Avionics Commercial | Avionics Total | Corporate Items | Total | |||||||||||||||
| Net sales | $ | 4,338,764 | $ | 737,265 | $ | 5,076,029 | $ | - | $ | 5,076,029 | ||||||||||
| Cost of sales | 2,665,561 | 584,880 | 3,250,441 | - | 3,250,441 | |||||||||||||||
| Gross margin | 1,673,203 | 152,385 | 1,825,588 | - | 1,825,588 | |||||||||||||||
| Engineering, research, and development | 583,771 | - | 583,771 | |||||||||||||||||
| Selling, general and administrative | 346,108 | 340,905 | 687,013 | |||||||||||||||||
| Litigation costs | 188,125 | 188,125 | ||||||||||||||||||
| Amortization of deferred financing costs | - | 1,357 | 1,357 | |||||||||||||||||
| Change in fair value of common stock warrants | - | (34,000 | ) | (34,000 | ) | |||||||||||||||
| Interest expense, net | - | 17,507 | 17,507 | |||||||||||||||||
| Total expenses | 929,879 | 513,894 | 1,443,773 | |||||||||||||||||
| Income (loss) before income taxes | $ | 895,709 | $ | (513,894 | ) | $ | 381,815 | |||||||||||||
Six Months Ended September 30, 2017 | Avionics Government | Avionics Commercial | Avionics Total | Corporate Items | Total | |||||||||||||||
| Net sales | $ | 4,001,019 | $ | 1,328,223 | $ | 5,329,242 | $ | - | $ | 5,329,242 | ||||||||||
| Cost of sales | 2,475,742 | 1,212,340 | 3,688,082 | - | 3,688,082 | |||||||||||||||
| Gross margin | 1,525,277 | 115,883 | 1,641,160 | - | 1,641,160 | |||||||||||||||
| Engineering, research, and development | 1,144,940 | - | 1,144,940 | |||||||||||||||||
| Selling, general and administrative | 636,185 | 696,496 | 1,332,681 | |||||||||||||||||
| Litigation costs | 425,845 | 425,845 | ||||||||||||||||||
| Legal damages | 2,100,000 | 2,100,000 | ||||||||||||||||||
| Amortization of deferred financing costs | - | 2,714 | 2,714 | |||||||||||||||||
| Change in fair value of common stock warrants | - | (90,000 | ) | (90,000 | ) | |||||||||||||||
| Proceeds from life insurance | (92,678 | ) | (92,678 | ) | ||||||||||||||||
| Interest expense, net | - | 24,338 | 24,338 | |||||||||||||||||
| Total expenses | 1,781,125 | 3,066,715 | 4,847,840 | |||||||||||||||||
| Income (loss) before income taxes | $ | (139,965 | ) | $ | (3,066,715 | ) | $ | (3,206,680 | ) | |||||||||||
Six Months Ended September 30, 2016 | Avionics Government | Avionics Commercial | Avionics Total | Corporate Items | Total | |||||||||||||||
| Net sales | $ | 9,210,384 | $ | 1,208,014 | $ | 10,418,398 | $ | - | $ | 10,418,398 | ||||||||||
| Cost of sales | 5,770,479 | 945,678 | 6,716,157 | - | 6,716,157 | |||||||||||||||
| Gross margin | 3,439,905 | 262,336 | 3,702,241 | - | 3,702,241 | |||||||||||||||
| Engineering, research, and development | 1,168,648 | - | 1,168,648 | |||||||||||||||||
| Selling, general and administrative | 689,990 | 770,052 | 1,460,042 | |||||||||||||||||
| Litigation expenses | 326,840 | 326,840 | ||||||||||||||||||
| Amortization of deferred financing costs | - | 2,713 | 2,713 | |||||||||||||||||
| Change in fair value of common stock warrants | - | (251,203 | ) | (251,203 | ) | |||||||||||||||
| Interest expense, net | - | 35,333 | 35,333 | |||||||||||||||||
| Total expenses | 1,858,638 | 883,735 | 2,742,373 | |||||||||||||||||
| Income (loss) before income taxes | $ | 1,843,603 | $ | (883,735 | ) | $ | 959,868 | |||||||||||||
Three Months Ended September 30, 2017 | Avionics Government | Avionics Commercial | Avionics Total | Corporate Items | Total | |||||||||||||||
Net sales | $ | 1,028,693 | $ | 758,472 | $ | 1,787,165 | $ | - | $ | 1,787,165 | ||||||||||
Cost of sales | 660,589 | 726,706 | 1,387,295 | - | 1,387,295 | |||||||||||||||
Gross margin | 368,104 | 31,766 | 399,870 | - | 399,870 | |||||||||||||||
Engineering, research, and development | 529,667 | - | 529,667 | |||||||||||||||||
Selling, general and administrative | 277,518 | 348,877 | 626,395 | |||||||||||||||||
Litigation costs | 43,333 | 43,333 | ||||||||||||||||||
Legal damages | 2,100,000 | 2,100,000 | ||||||||||||||||||
Amortization of deferred financing costs | - | 1,357 | 1,357 | |||||||||||||||||
Change in fair value of common stock warrants | - | 5,000 | 5,000 | |||||||||||||||||
Proceeds from life insurance | - | - | ||||||||||||||||||
Interest expense, net | - | 14,707 | 14,707 | |||||||||||||||||
Total expenses | 807,185 | 2,513,274 | 3,320,459 | |||||||||||||||||
Loss before income taxes | $ | (407,315 | ) | $ | (2,513,274 | ) | $ | (2,920,589 | ) | |||||||||||
Six Months Ended September 30, 2018 | Avionics Government | Avionics Commercial | Avionics Total | Corporate Items | Total | |||||||||||||||
Net sales | $ | 2,376,681 | $ | 1,660,474 | $ | 4,037,155 | $ | - | $ | 4,037,155 | ||||||||||
Cost of sales | 1,475,844 | 1,080,785 | 2,556,629 | - | 2,556,629 | |||||||||||||||
Gross margin | 900,837 | 579,689 | 1,480,526 | - | 1,480,526 | |||||||||||||||
Engineering, research, and development | 1,020,703 | - | 1,020,703 | |||||||||||||||||
Selling, general and administrative | 411,307 | 710,629 | 1,121,936 | |||||||||||||||||
Litigation costs | 75,119 | 75,119 | ||||||||||||||||||
Interest income | - | (2,007 | ) | (2,007 | ) | |||||||||||||||
Interest expense - judgment | 143,223 | 143,223 | ||||||||||||||||||
Interest expense | - | 59,035 | 59,035 | |||||||||||||||||
Total expenses | 1,432,010 | 985,999 | 2,418,009 | |||||||||||||||||
Income (loss) before income taxes | $ | 48,516 | $ | (985,999 | ) | $ | (937,483 | ) | ||||||||||||
Six Months Ended September 30, 2017 | Avionics Government | Avionics Commercial | Avionics Total | Corporate Items | Total | |||||||||||||||
Net sales | $ | 4,001,019 | $ | 1,328,223 | $ | 5,329,242 | $ | - | $ | 5,329,242 | ||||||||||
Cost of sales | 2,475,742 | 1,212,340 | 3,688,082 | - | 3,688,082 | |||||||||||||||
Gross margin | 1,525,277 | 115,883 | 1,641,160 | - | 1,641,160 | |||||||||||||||
Engineering, research, and development | 1,144,940 | - | 1,144,940 | |||||||||||||||||
Selling, general and administrative | 636,185 | 696,496 | 1,332,681 | |||||||||||||||||
Litigation costs | 425,845 | 425,845 | ||||||||||||||||||
Legal damages | 2,100,000 | 2,100,000 | ||||||||||||||||||
Amortization of deferred financing costs | - | 2,714 | 2,714 | |||||||||||||||||
Change in fair value of common stock warrants | - | (90,000 | ) | (90,000 | ) | |||||||||||||||
Proceeds from life insurance | (92,678 | ) | (92,678 | ) | ||||||||||||||||
Interest expense, net | - | 24,338 | 24,338 | |||||||||||||||||
Total expenses | 1,781,125 | 3,066,715 | 4,847,840 | |||||||||||||||||
Loss before income taxes | $ | (139,965 | ) | $ | (3,066,715 | ) | $ | (3,206,680 | ) | |||||||||||
TEL-INSTRUMENT ELECTRONICS CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 11 – Income Taxes
FASB ASC 740-10, “Accounting for Uncertainty in Income Taxes” (“ASC 740-10”) prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The Company has analyzed filing positions in all of the federal and state jurisdictions where it is required to file income tax returns, as well as all open tax years in these jurisdictions. The Company does not have any unrecognized tax benefits.
The tax effect of temporary differences, primarily net operating loss carryforwards, asset reserves and accrued liabilities, gave rise to the Company’s deferred tax asset. Deferred income taxes are recognized for the tax consequence of such temporary differences at the enacted tax rate expected to be in effect when the differences reverse. The Company has approximately $3.5 million in deferred tax assets, and we have provided a 100%valuation allowance that offsets the majority of the asset. The inability to obtain new profitable contracts or the failure of the Company’s engineering development efforts could reduce estimates of future profitability, which could affect the Company’s ability to realize the deferred tax assets. Due to the adverse judgment and the resulting losses the past few years, management has established a valuation allowance against itsthis deferred tax asset at September 30, 2017asset. This valuation allowance could be reversed when the Company returns to profitability, and March 31, 2017.
Note 1212 – Fair Value Measurements
FASB ASC 820-10, Fair Value Measurements and Disclosures (“ASC 820-10”) defines fair value, establishes a framework for measuring fair value under generally accepted accounting principles and expands disclosures about fair value measurements.
As defined in ASC 820-10, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observation of those inputs. ASC 820-10 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).
The three levels of the fair value hierarchy defined by ASC 820-10 are as follows:
- | Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities. |
- | Level 2 – Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars. |
- | Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value. |
TEL-INSTRUMENT ELECTRONICS CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 12 – Fair Value Measurements (continued)
The valuation techniques that may be used to measure fair value are as follows:
● | Market approach — Uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. |
● | Income approach — Uses valuation techniques to convert future amounts to a single present amount based on current market expectations about those future amounts, including present value techniques, option-pricing models and excess earnings method. |
● | Cost approach — Based on the amount that currently would be required to replace the service capacity of an asset (replacement cost). |
The carrying value of the Company’s borrowings is a reasonable estimate of its fair value as borrowings under the Company’s credit facility reflect currently available terms and conditions for similar debt.
| September 30, 2017 | Level I | Level II | Level III | Total | ||||||||||||
| Total Assets | $ | - | $ | - | $ | - | $ | - | ||||||||
| Warrant liability | - | - | 5,000 | 5,000 | ||||||||||||
| Total Liabilities | $ | - | $ | - | $ | 5,000 | $ | 5,000 | ||||||||
| March 31, 2017 | Level I | Level II | Level III | Total | ||||||||||||
| Total Assets | $ | - | $ | - | $ | - | $ | - | ||||||||
| Warrant liability | - | - | 95,000 | 95,000 | ||||||||||||
| Total Liabilities | $ | - | $ | - | $ | 95,000 | $ | 95,000 | ||||||||
| Level 3 Reconciliation | Balance at beginning of period | (Gains) and losses for the period (realized and unrealized) | Purchases, issuances, sales and settlements, net | Transfers in or out of Level 3 | Balance at the end of period | |||||||||||||||
| Warrant liability | $ | 95,000 | $ | (90,000 | ) | $ | - | $ | - | $ | 5,000 | |||||||||
| Total Liabilities | $ | 95,000 | $ | (90,000 | ) | $ | - | $ | - | $ | 5,000 | |||||||||
Note 1313 – ReclassificationsSeries A 8% Convertible Preferred Stock
On November 14, 2017, the Company entered into definitive subscription agreements with an accredited investor, pursuant to conformwhich the investor purchased an aggregate of 500,000 shares of the Company’s Series A Preferred Stock (the “Series A Preferred”) for an aggregate of $3 million. The Company intends to use such proceeds for the payment of any Court judgment and/or settlement related to the current period presentation.
The shares of Series A Preferred have a stated value of $6.00 per share (the “Series A Stated Value”) and are convertible into Common Stock at a price of $3.00 per share. The holders of shares of the Series A Preferred shall be entitled to receive dividends out of any assets legally available, to the extent permitted by New Jersey law, at an annual rate equal to 8% of the Series A Stated Value of such shares of Series A Preferred, calculated on the basis of a 360 day year, consisting of twelve 30-day months, and shall accrue from the date of issuance of such shares of Series A Preferred, payable quarterly in cash. Any unpaid dividends shall accrue at the same rate. To the extent not paid on the last day of March, June, September and December of each calendar year, all dividends on any share of Series A Preferred shall accumulate whether or not declared by the Board and shall remain accumulated dividends until paid. As of March 31, 2018, the Company accrued $90,667 for dividends. Since there were not sufficient authorized shares to allow for full conversion of the preferred stock into common stock at December 31, 2017, preferred stock was classified as mezzanine equity. At the January 2018 annual meeting approval was obtained for the additional authorized shares. As such, preferred stock will now be classified as permanent stockholders’ equity.
The Holders will vote together with the holders of the Company’s Common Stock on an as-converted basis on each matter submitted to a vote of holders of Common Stock (whether at a meeting of shareholders or by written consent). Effective beginning on the third anniversary of the Original Issue Date, and upon 30 days’ written notice to the Holders of Series A Preferred, the Company may, in its sole discretion, redeem the Series A Preferred at the aggregate Series A Stated Value plus any accrued and accumulated but unpaid dividends.
TEL-INSTRUMENT ELECTRONICS CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1414 – Litigation
Contingencies are recorded in the consolidated financial statements when it is probable that a liability will be incurred and the amount of the loss is reasonably estimable, or otherwise disclosed, in accordance with Accounting Standards Codification 450, Contingencies (“ASC 450”)(ASC 450). Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. In the event the Company determines that a loss is not probable, but is reasonably possible, and it becomes possible to develop what the Company believes to be a reasonable range of possible loss, then the Company will include disclosures related to such matter as appropriate and in compliance with ASC 450. To the extent there is a reasonable possibility that the losses could exceed the amounts already accrued, the Company will, when applicable, adjust the accrual in the period the determination is made, disclose an estimate of the additional loss or range of loss or if the amount of such adjustment cannot be reasonably estimated, disclose that an estimate cannot be made.
On March 24, 2009, Aeroflex Wichita, Inc. (“Aeroflex”) filed a petition against the Company and two of its employees in the District Court located in Sedgwick County, Kansas, Case No. 09 CV 1141 (the “Aeroflex Action”), alleging that the Company and its two employees misappropriated Aeroflex’s proprietary technology in connection with the Company winning a substantial contract from the U.S. Army, to develop new Mode-5 radar test sets and kits to upgrade the existing TS-4530 radar test sets to Mode 5 (the “Award”). Aeroflex’s petition, seeking injunctive relief and damages, alleges that in connection with the Award, the Company and its named employees misappropriated Aeroflex’s trade secrets; tortiously interfered with Aeroflex’s business relationship; conspired to harm Aeroflex and tortiously interfered with Aeroflex’s contract. The central basis of all the claims in the Aeroflex Action is that the Company misappropriated and used Aeroflex proprietary technology and confidential information in winning the Award. In February 2009, subsequent to the Company winning the Award, Aeroflex filed a protest of the Award with the Government Accounting Office (“GAO”).
In its protest, Aeroflex alleged, inter alia, that the Company used Aeroflex’s proprietary technology in order to win the Award, the same material allegations as were later alleged in the Aeroflex Action. On or about March 17, 2009, the U.S. Army Contracts Attorney and the U.S. Army Contracting Officer each filed a statement with the GAO, expressly rejecting Aeroflex’s allegations that the Company used or infringed on Aeroflex’s proprietary technology in winning the Award, and concluding that the Company had used only its own proprietary technology. On April 6, 2009, Aeroflex withdrew its protest.
In December 2009, the Kansas District Court dismissed the Aeroflex Action on jurisdiction grounds. Aeroflex appealed this decision. In May 2012, the Kansas Supreme Court reversed the decision and remanded the Aeroflex Action to the Kansas District Court for further proceedings.
On May 23, 2016, the Company filed a motion for summary judgment based on Aeroflex’s lack of jurisdictional standing to bring the case. The motion asserts that Aeroflex does not own the intellectual property at issue since it is a bare licensee of Northrop Grumman. Northrop Grumman has declined to join this suit as plaintiff. Aeroflex lacks standing to sue alone. Also, the motion raises the fact that Aeroflex allowed the license to expire,expire. Aeroflex’s claims are either moot or Aeroflex lacks standing to sue for damages alleged to have accrued after the license ended in 2015 2011. The motion for summary judgment was denied.
The Aeroflex trial on remand in the Kansas District Court began in March 2017. After a six-weeknine-week trial, the jury rendered its verdict. The jury found no misappropriation of Aeroflex trade secrets but it did rule that the Company tortiously interfered with a prospective business opportunity and awarded damages of $1.3 million for lost profits. The jury also ruled that Tel tortiously interfered with Aeroflex’s non-disclosure agreements with two former Aeroflex employees and awarded damages of $1.5 million for lost profits, resulting in total damages against the Company of $2.8 million. The jury also found that the former Aeroflex employees breached their non-disclosure agreements with Aeroflex and awarded damages against these two individuals totaling $525,000. The jury also decided that punitive damages should be allowed against the Company.
Following the verdict, the Company filed a motion for judgment as a matter of law. In the motion, the Company renewed its motion for judgment on Aeroflex’s tortious interference with prospective business opportunity claim arguing that such claim is barred by the statute of limitations. Alternatively, the motion asserts there is insufficient evidence supporting the lost profit award on that claim. Additionally, the motion for judgment addresses inconsistency between the awards against the former Aeroflex employees for breach of the non-disclosure agreements and the award against the Company for interfering with those agreements. Alternatively, the motion asserts there is insufficient evidence supporting the lost profit award on that claim.
TEL-INSTRUMENT ELECTRONICS CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 14 – Litigation (continued)
During July 2017, the Court heard the Company’s motion for judgment as well as conducting a hearing as to the amount of a punitive damages award. Kansas statutes limit punitive damages to a maximum of $5 million.
Aeroflex submitted a motion to the Court requesting that the judge award punitive damages at the maximum $5 million amount. In Kansas, punitive damages are awarded to “punish the wrongdoer for his malicious, vindictive or willful and wanton invasion of another’s rights, with the ultimate purpose being to restrain and deter others from the commission of similar wrongdoings.” Importantly, Kansas courts have ruled that the purpose of punitive damages “is to sting, not to kill”. The Court will also take into consideration the Company’s financial condition in setting the amount of punitive damages.
The Company filed motions in January 2018 for the court, and we have filed a motion withCourt to reconsider the courtamount of damages on the grounds that these changesthey are duplicative and not supported by Kansas Law.
On July 5, 2018, Plaintiff Aeroflex Wichita, Inc. filed a Notice of Cross-Appeal which is contingent in nature in that it seeks a review of all adverse rulings relating to its Motion for Relief and Sanctions; Defendants’ Motions for Summary Judgment; determining that certain matters were not trade secrets; Defendants’ joint and several liability; preemption under the Company signedKansas Uniform Trade Secrets Act; motions in limine; motions for judgment as a subscription agreementmatter of law; jury instructions; admission of evidence over its objections; and all other ruling adverse to it only if the court reverses the jury verdict and judgment. Aeroflex Wichita also reserved the right to ask the reviewing court to order a new trial either on damages alone or on liability for all claims. This reservation of rights is also contingent upon a finding of the appellate court which would reverse the jury verdict and judgment. Aeroflex Wichita filed its Docketing Statement the same day.
On July 11, 2018, the Court of Appeals entered an Order of Referral to Mediation and Order to Stay. The Company’s case was selected to participate in which the Company received $3 million for Series A Convertible Preferred Stock (See Note 16Kansas Court of Appeals Appellate Mediation pilot program. Participation in the program is voluntary, either party may opt out of participation. The order staying the case was lifted because Aeroflex Wichita, Inc. opted out, and as a result the appeal will proceed under normal procedures.The appeal process is anticipated to the Notestake several years to the Condensed Financial Statements). These funds will be used to finance an appeal and provide funds for operations.
Other than the matters outlined above, we are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of executive officers of our Company, threatened against or affecting our Company, or our common stock in which an adverse decision could have a material effect.
Note 15 – New Accounting Pronouncements
TEL-INSTRUMENT ELECTRONICS CORP.Recently Adopted Authoritative Pronouncements
Revenue Recognition
In May 2014, the FASB issued ASU 2014-09, that introduces a new five-stepRevenue from Contracts with Customers: Topic 606 which supersedes nearly all existing revenue recognition model in which an entity shouldguidance under GAAP. The core principle of Topic 606 is to recognize revenue to depict the transfer ofrevenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which the entity expectsthat is expected to be entitledreceived for those goods or services. The ASU defines a five-step process to achieve the core principal and, in doing so, it is possible more judgement and estimates may be required within the revenue recognition process than are currently in use. The ASU was effective for the Company in the first quarter of 2019 using either of two methods: (1) retrospective application to each prior reporting period presented with the option to elect certain practical expedients or (2) retrospective application with the cumulative effect of initially applying the ASU recognized at the date of the initial application and providing certain disclosures. We adopted Topic 606 pursuant to the method (2) and we determined that any cumulative effect for the initial application did not require an adjustment to retained earnings at April 1, 2018.
The Company generates revenue from designing, manufacturing and selling avionic tests and measurement solutions for the global commercial air transport, general aviation, and government/military aerospace and defense markets. The Company also offers calibration and repair services for a wide range of airborne navigation and communication equipment.
TEL-INSTRUMENT ELECTRONICS CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 15 – New Accounting Pronouncements (continued)
Recently Adopted Authoritative Pronouncements (continued)
Revenue Recognition (continued)
Under Financial Accounting Standards Board (“FASB”) Topic 606, Revenue from Contacts with Customers (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods or services, in an amount that reflects the consideration which is expected to be received in exchange for those goods or services. This ASU also requires disclosures sufficientThe Company recognizes revenue following the five-step model prescribed under ASC 606: (i) identify contract(s) with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to enable usersthe performance obligation(s) in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to understandcontracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.
Nature of goods and services
The following is a description of the products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each.
Test Units/Sets
The Company develops, and manufactures unit sets to test navigation and communication equipment, such as ramp testers and bench testers for radios installed in aircraft. The Company recognizes revenue when the customer obtains control of the Company’s product based on the contractual shipping terms of the contract. Revenue on products are presented gross because the Company is primarily responsible for fulfilling the promise to provide the product, is responsible to ensure that the product is produced in accordance with the related supply agreement, and bears the risk of loss while the inventory is in-transit. Revenue is measured as the amount timing,of consideration the Company expects to receive in exchange for transferring products to the customer.
If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products or services underlying each performance obligation. The Company determines stand-alone selling prices based on the price at which the performance obligation is sold separately. If the stand-alone selling price is not observable through past transactions, the Company estimates the standalone selling price taking into account available information such as market conditions and uncertaintyinternally approved pricing guidelines related to the performance obligations.
When determining the transaction price of a contract, an adjustment is made if payment from the customer occurs either significantly before or significantly after performance, resulting in a significant financing component. Applying the practical expedient in paragraph 606-10-32-18, the Company does not assess whether a significant financing component exists if the period between when the Company performs its obligations under the contract and when the customer pays is one year or less. None of the Company’s contracts contained a significant financing component as of September 30, 2018.
Replacement Parts
The Company offers replacement parts for test equipment, ramp testers, and bench testers. Similar to the sale of test units, the control of the product transfers at a point of time and therefore, revenue is recognized at the point in time when the obligation to the customer has been fulfilled.
TEL-INSTRUMENT ELECTRONICS CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 15 – New Accounting Pronouncements (continued)
Recently Adopted Authoritative Pronouncements (continued)
Revenue Recognition (continued)
Extended Warranties
The extended warranties sold by the Company provide a level of assurance beyond the coverage for defects that existed at the time of a sale or against certain types of covered damage with coverage terms generally ranging from 5 to 7 years. Amounts received for warranties are recorded as deferred revenue and cash flows arisingrecognized as revenue ratably over the respective term of the agreements. As of September 30, 2018, approximately $640,690 is expected to be recognized from remaining performance obligations for extended warranties. For the six months ended September 30, 2018, the Company recognized revenue of $19,621 from amounts that were included in Deferred Revenue.
Repair and Calibration Services
The Company offers repair and calibration services for units that are returned for annual calibrations and/or for repairs after the warranty period has expired. The Company repairs and calibrates a wide range of airborne navigation and communication equipment. Revenue is recognized at the time the repaired or calibrated unit is shipped, as it is at this time that the work is completed.
The majority of the Company’s revenues are from contracts with the U.S. government, airlines, aircraft manufacturers, such as Boeing and Lockheed Martin, domestic distributors, international distributors for sales to military and commercial customers, including qualitative and quantitative disclosures aboutother commercial customers. The contracts with customers, significant judgmentsthe U.S. government typically are subject to the Federal Acquisition Regulation (“FAR”) which provides guidance on the types of costs that are allowable in establishing prices for goods and changesservices provided under U.S. government contracts.
Payment terms and conditions vary by contract, although terms generally include a requirement of payment within a range from 30 to 60 days, or in judgments, and assets recognizedcertain cases, up-front deposits. In circumstances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined that the Company's contracts generally do not include a significant financing component. Payments received prior to the delivery of units or services performed are recorded as deferred revenues. Taxes collected from customers, which are subsequently remitted to governmental authorities, are excluded from sales. Shipping and handling costs charged to obtain or fulfill a contract. customers are classified as sales, and the shipping and handling costs incurred are included in cost of sales.
Disaggregation of revenue
In Marchthe following table, revenue is disaggregated by revenue category.
For the Three Months Ended September 30, 2018 | ||||||||
Commercial | Government | |||||||
Sales Distribution | ||||||||
Test Units | $ | 261,992 | $ | 1,284,099 | ||||
Repairs and Calibration | 586,577 | - | ||||||
Replacement Parts | 79,586 | - | ||||||
Extended Warranty | 10,687 | - | ||||||
| $ | 938,842 | $ | 1,284,099 | |||||
TEL-INSTRUMENT ELECTRONICS CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 15 – New Accounting Pronouncements (continued)
Recently Adopted Authoritative Pronouncements (continued)
Revenue Recognition (continued)
Disaggregation of revenue
For the Six Months Ended September 30, 2018 | ||||||||
Commercial | Government | |||||||
Sales Distribution | ||||||||
Test Units | $ | 596,224 | $ | 2,376,681 | ||||
Repairs and Calibration | 919,276 | - | ||||||
Replacement Parts | 125,354 | - | ||||||
Extended Warranty | 19,620 | - | ||||||
| $ | 1,660,474 | $ | 2,376,681 | |||||
In February 2016, the FASB issued ASU 2016-08No. 2016-02, Leases (Topic 842), which further clarifiesrequires lessees to put most leases on their balance sheets by recognizing a lessee’s rights and obligations, while expenses will continue to be recognized in a similar manner to today’s legacy lease accounting guidance. This ASU could also significantly affect the guidance on the principal versus agent considerations within ASU 2014-09. In April 2016, the FASB issued ASU 2016-10 to expand the guidance on identifying performance obligations and licensing within ASU 2014-09. In May 2016, the FASB issued ASU 2016-12 to improve revenue recognition in the areas of collectability, presentation of sales taxfinancial ratios used for external reporting and other similar taxes collected from customers, noncash consideration, contract modifications and completed contracts at transition.purposes, such as debt covenant compliance. This update also amends the disclosure requirements within ASU 2014-09 for entities that retrospectively apply the guidance. The latest amendments are intended to address implementation issues that were raised by stakeholders and discussed by the Revenue Recognition Transition Resource Group, and provide additional practical expedients. These standards arewill be effective for fiscal years beginning after December 15, 2017, including interim periods within that reporting period.the Company on April 1, 2019, with early adoption permitted. The Company is currently evaluatingin the new guidance to determineprocess of assessing the impact if any, it will haveof this ASU on itsour consolidated financial statements.
No other recently issued accounting pronouncements had or are expected to have a material impact on the Company’s condensed consolidated financial statements.
Note 1616 – Subsequent Event
On October 2, 2018, the Company established 166,667 shares of the Company’s the Series B Convertible Preferred Stock (the “Series B Preferred”), having such designations, rights and preferences as set forth therein, as determined by the Company’s Board of Directors in its sole discretion, in accordance with the Company’s Certificate of Incorporation and bylaws. The shares of Series B Preferred have a stated value of $6.00 per share (the “Series B Stated Value”) and are convertible into Common Stock at a price of $2.00 per share, subject to adjustment (the “Conversion Price”). The holders of shares of the Series B Preferred shall be entitled to receive dividends out of any assets legally available, to the extent permitted by New Jersey law, at an annual rate equal to 8% of the Series B Stated Value of such shares of Series B Preferred, calculated on the basis of a 360 day year, consisting of twelve 30-day months, and shall accrue from the date of issuance of such shares of Series B Preferred, payable quarterly in cash.
On October 5, 2018, the Company entered into a definitive subscription agreement with an existing stockholderaccredited investor, pursuant to provide $3 million in exchange for Series A Convertible Preferred Stock. The Series A Preferred Stock haswhich the rights, privileges, preferences and restrictions set for in the Certificateinvestor purchased an aggregate of Amendment to Certificate of Incorporation (the “Designations”) filed by the Company with the Secretary of State of the State of New Jersey on November 8, 2017. The Designations provide for an 8% dividend rate and Series A Preferred Stock is convertible into shares of common stock at a price of $3.00 per share.
Forward Looking Statements
This Quarterly Report on Form 10-Q and other reports filed by the Company from time to time with the SEC (collectively the “Filings”) contain or may contain forward-looking statements and information that are based upon beliefs of, and information currently available to, the Company’s management as well as estimates and assumptions made by Company’s management. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. When used in the Filings, the words “may”, “will”, “anticipate”, “believe”, “estimate”, “expect”, “future”, “intend”, “plan”, or the negative of these terms and similar expressions as they relate to the Company or the Company’s management are intended to identify forward-looking statements. Such statements reflect the current view of the Company with respect to future events and we caution you that these statements are not guarantees of future performance or events and are subject to risks, uncertainties, assumptions, and other factors, including the risks contained in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended March 31, 2017, filed with the SEC on July 14, 2017, relating to the Company’s industry, the Company’s operations and results of operations, and any businesses that the Company may acquire.factors. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned.
Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.
Our financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). These accounting principles require us to make certain estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our financial statements would be affected to the extent there are material differences between these estimates and actual results. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management’s judgment in its application. There are also areas in which management’s judgment in selecting any available alternative would not produce a materially different result. The following discussion should be read in conjunction with our financial statements and notes thereto appearing elsewhere in this report.
Overview
As previously reported, the Company has received a $4.3 million order for Mode 5 test sets from the U.S. military. In August 2018, we also reported that the German government had notified our U.K. distributor of its intent to award a multi-year, multi-million dollar contract for the purchase of up to 275 TS-4530A Mode 5 test sets. The German government has received a protest to this planned award from an unsuccessful bidder, and this must be resolved prior to any contract being awarded. We are hoping for a positive outcome before the end of this calendar year, but can make no guarantees of such result.
The Company continues to pursue international opportunitiesits negotiations with its "Drive to Mode 5" marketing campaign. All allied countries haveLockheed Martin on a drop dead date of January 1, 2020 for implementing Mode 5 capability; as a result,test set order for approximately $800,000 which is expected to be received within the next 30 days with another larger order to be received within 90 days. These units for Lockheed Martin will be used for the Joint Strike Fighter (“JSF”) program, and we believe this program will generate significant CRAFT orders as this program ramps up limited rate production. The Company has already received orders from Lockheed Martin for the AN/USM-708 units, for the JSF Program, totaling approximately $5 million. Sikorsky has also indicated that it will be ordering CRAFT test sets for its new helicopters. The Company also receives orders from other customers for this product.
The Company is also in discussions with other major international customers that have evaluated our Mode 5 business will remain strongtest sets and we are excited about the opportunities overseas, as evidenced by the above-mentioned pending order from Germany, an order from Japan for at least$400,000as well as the next three years.interest we have been receiving from other countries, such as Australia, Canada, United Kingdom and South Korea. The Company believes it has built a very solid position in the Mode 5 IFF and TACANIdentification Friend or Foe (“IFF”) flight line test setequipment market, and theseour products should beare very competitive in both the domesticoverseas markets. We believe that we are well-positioned as our CRAFT and overseas markets,TS-4530A flight-line test sets have been endorsed by the U.S. military and we have already delivered Mode 5 test sets into 18 international markets.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations (continued).
Overview (continued)
The commercial avionics industry is undergoing a great deal of change and we believe our new lightweight, hand-held products that we are planning to introduce in the real long-term growth potentialnear term will generate increased market share at very attractive gross margin levels. The technology for the Company is inhand-held product will provide a platform for future products. We are also working closely with our other military customers on new line of modular hand-held test sets. potential market opportunities that will be needed to maintain our sales and profitability growth.
This providesnew technology could provide us with the opportunity to expand out of our relatively narrow avionics test market niche and enter the much larger secure communications radio test market. We are actively working to line up partners to enter this growth market and we believe that our new hardware platform provides unmatched capabilities in a market leading form factor. TheIn March 2018, the Company is also evaluating upcoming U.S. Navy requirements, and expects at least one large competitive solicitation will be issued in the next 12 months for a product in our technical area of expertise. We are also working closely with our other military customers on new potential market opportunities that will be needed to maintain our sales and profitability growth.
The initial SDR-OMNI software release will provide test capability for Transponders (Modes A, C, and S), ADS-B, and 978 MHz UAT navigationcapability for the large general aviation market. We believe that our new hand-held products, that we are planning to introduce in the near term, will generate increased market share at attractive gross margin levels. The Company is also targeting the extremely large commercial and military radio test set market which is many times the size of our traditional avionics test market. We are also working closely withThis release is targeted at the civil aviation market that is subject to the January 1, 2020 requirement for ADS-B out capability. The initial version of this product should be available towards the end of current fiscal year. The next software release will incorporate Nav/Comm test functions which can be purchased as APP’s by our military customers on new potential market opportunities that will be needed to maintain our sales and profitability growth.
The Aeroflex litigation (see Note 14) did not result in a favorable outcome for the Company, despite our belief that we committed no wrong doing. The Judge did not change the result or vacate the damage award based on our latest motions, and, as such, we are appealing this decision, and filed the appeal document (the “Appeal”) the week of May 28, 2018. The Company has posted a $2,000,000 bond to prevent Aeroflex from enforcement actions until a final decision has been rendered by the Court. This $2 million bond amount would remain in place during the appeal process which would be expected to take several years to complete. We believe that we will have approximately two to three years to generate sufficient cash or secure additional financing to support the repayment of the remaining $2.9 million not covered by the $2 million appeal bond, if we do not prevail with the appeal.
In October 2018, the Company entered into a subscription agreement pursuant to which an investor purchased 166,667 shares of the Company’s Series B Preferred Stock for $1 million. These funds will be used for working capital purposes to support the orders received and expected in the near term.
On August 8, 2018, the Company received a letter from the staff of the NYSE American (the “Exchange”) stating that based on the Company’s financial statements at March 31, 2018, the Company is not in compliance with Section 1003(a)(ii) of the NYSE American Company Guide, which requires that a company’s stockholders’ equity be $4.0 million or more if it has reported net losses in three of its last four fiscal years (the “Stockholders’ Equity Requirement”).
As of March 31, 2018, the Company had a stockholders’ deficit of approximately $1.4 million, and had net losses in three of its last four fiscal years, thus bringing the Company below the Stockholders’ Equity Requirement. The decline in equity primarily resulted from the accrual of approximately $5 million in damages arising from the Aeroflex litigation as well as over $2 million in litigation costs over the years. The Company also had to record a valuation allowance of approximately $3.5 million against the Company’s deferred tax asset.
The Company is preparing a plan (the “Plan”) that will be submitted to the Exchange describing the actions the Company is considering taking to regain compliance with the Stockholders’ Equity Requirement. The Company has also been advised that it will be subject to delisting proceedings if it does not regain compliance prior to the deadline of January 29, 2019, or if the Exchange determines that Company is not making progress consistent with the Plan. The Company’s stock will continue to be listed on the NYSE American while the Company evaluates it various alternatives. The Company’s receipt of such notification from the Exchange does not affect the Company’s business, operations or reporting requirements with the U.S. Securities and Exchange Commission. The Company continues to work with the Exchange, but there is no assurance that it will remain listed on the Exchange.
At September 30, 2018, the Company’s backlog of orders was approximately $1.4 million as compared to $1.6 million at September 30, 2017. The backlog at September 30, 2018 does not include the $4.3 million Mode 5 order received and announced in October 2018 nor the pending orders from Lockheed Martin and Germany. Historically, the Company obtains orders which are required to be filled in less than 12 months, and therefore, these anticipated orders are not reflected in the backlog. With the pending Mode 5 deadline at January 1, 2020, the Company expects the backlog and sales to be increasing in the second half of the current fiscal year.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Overview (continued)
The expectationCompany continues to pursue additional financing opportunities. Financing discussions have been taking place with various parties, but the Company has no firm commitment from any party to provide additional funding at this time. Moreover, there is no assurance that wesufficient funding will significantly improvebe available, or if available, that its terms will be favorable to the Company. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Results of Operations
Sales
For the three months ended September 30, 2018, total net sales increased $435,776 (24.4%) to $2,222,941 as compared to $1,787,165 for the three months ended September 30, 2017. Avionics government sales increased $255,406 (24.8%) to $1,284,099 for the three months ended September 30, 2018, as compared to $1,028,693 for the three months ended September 30, 2017. The increase in sales is mostly attributed to the increase in shipment of the new T-47/M5, ITATS, and the T-47NH offset partially by decreases in the shipment of the TS-4530A, CRAFT products and other legacy products. Commercial sales increased $180,370 (23.8%) to $938,842 for the three months ended September 30, 2018 as compared to $758,472 for the three months ended September 30, 2017. This increase is attributed to the increased sales from our gross margins beginning nextrepair business and the TR-36 offset partially by lower sales of the TR-220.
For the six months ended September 30, 2018, total net sales decreased $1,292,087 (24.2%) to $4,037,155, as compared to $5,329,242 for the six months ended September 30, 2017. Avionics government sales decreased $1,624,338 (40.6%) to $2,376,681 for the six months ended September 30, 2018, as compared to $4,001,019 for the six months ended September 30, 2017. The decrease in sales is mostly attributed to the decrease in shipment of the U.S. Army TS-4530A which is now completed, CRAFT units and certain other legacy products, partially offset by the increase in sales associated with the shipments of the T-47/M5. Commercial sales increased $332,251 (25.0%) to $1,660,474 for the six months ended September 30, 2018 as compared to $1,328,223 for the six months ended September 30, 2017. This increase is attributed to the increased sales from our repair business and the TR-36 offset partially by lower sales of the TR-220.
As discussed above in the overview section, sales are expected to increase in the second half of the current fiscal year withas a goalresult of returning tothe $4.3 million order for additional Mode 5 test sets from the U.S. military as well as other large expected orders for our traditional 50%Mode 5 test sets both domestically and internationally.
Gross Margin
For the three months ended September 30, 2018, total gross margin levels. As such, we believeincreased $599,343 (149.9%) to $999,213 as compared to $399,870 for the key will bethree months ended September 30, 2017 primarily as a result of the reduction in manufacturing overhead as well as manufacturing efficiencies and the increase in volume . The gross margin percentage for the three months ended September 30, 2018 was 45.0% as compared to secure sufficient high22.4% for the three months ended September 30, 2017. The higher gross margin businesspercentage is attributable to the reduction in manufacturing overhead as well as manufacturing efficiencies.
For the six months ended September 30, 2018, total gross margin decreased $160,634 (9.8%) to $1,480,526 as compared to $1,641,160 for the six months ended September 30, 2017 primarily as the lower volume offset partially by the reduction in manufacturing overhead and improvement in manufacturing efficiencies as well as higher prices. The gross margin percentage for the six months ended September 30, 2018 was 36.7% as compared to 30.8% for the three months ended September 30, 2017. The higher gross margin percentage is attributable to the reduction in manufacturing overhead as well as manufacturing efficiencies.
Operating Expenses
Selling, general and administrative expenses decreased $70,984 (11.3%) to $555,411 for the three months ended September 30, 2018 as compared to $626,395 for the three months ended September 30, 2017, respectively. This decrease is primarily attributed to lower salaries and related expenses as well as lower commission expenses.
Selling, general and administrative expenses decreased $210,745 (15.8%) to $1,121,936 for the six months ended September 30, 2018 as compared to $1,332,681 for the six months ended September 30, 2017, respectively. This decrease is primarily attributed to lower salaries and related expenses as well as lower commission and travel expenses partially offset by higher consulting fees.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations (continued).
Results of Operations (continued)
Litigation costs decreased $7,485 and $350,726 to $35,848 and $75,119 for the three and six months ended September 30, 2018, respectively, as compared to $43,333 and $425,845 for the three and six months ended September 30, 2017, respectively, as a result of less activity associated with our existingthe Aeroflex litigation. The Company has filed its appeal (see Notes 5 and new products14 to maintain a reasonable backlog. The timing of these new orders is largely out of our hands so we expectNotes to see increased volatility in our quarterly revenues during fiscal year 2018. Atthe Condensed Consolidated Financial Statements).
For the three and six months ended September 30, 2017, the Company’s backlogCompany recorded $2.1 million in additional legal damages as a result of orders was approximately $1.6 millionthe court’s decision regarding punitive damages last year (see Note 14 to Notes to the Condensed Consolidated Financial Statements).
Engineering, research and development expenses decreased $26,287 (5.0%) and $124,237 (10.9%) to $503,380 and $1,020,703 for the three and six months ended September 30, 2018, respectively, as compared to $3.2 million$529,667 and $1,144,940 for the three and six months ended September 30, 2017, respectively. The Company also continues to invest in the development of the Company’s hand-held product line utilizing CRAFT and TS-4530A technology and the T47-M5 test set, the enhanced remote client, and the incorporation of other product enhancements in existing designs.
Loss from Operations
As a result of the above, the Company recorded losses from operations of $95,426 and $737,232 for the three and months ended September 30, 2018, respectively, as compared to losses from operations of $2,899,525 and $3,362,306 for the three and six months ended September 30, 2017, respectively.
Other Income (Expense), Net
For the three months ended September 30, 2018, total other expense was $95,984, as compared to other expense of $21,064 for the three months ended September 30, 2017 as a result of accrued interest expense related to the judgment on the Aeroflex litigation.
For the six months ended September 30, 2018, total other expense was $200,251 as compared to other income of $155,626 for the six months ended September 30, 2017. The six months ended September 30, 2017 included a gain on the change in the valuation of common stock warrants as well as proceeds from a life insurance policy which did not occur in the during the first six months of the current fiscal year ended September 30, 2018.
Loss before Income Taxes
As a result of the above, the Company recorded losses before taxes of $191,410 and $937,483 for the three and six months ended September 30, 2018, respectively, as compared to losses before taxes of $2,920,589 and $3,206,680 for the three and six months ended September 30, 2017, respectively.
Income Tax Benefit
For the three and six months ended September 30, 2018 and September 30, 2017, the Company recorded no income tax benefit as such amounts were offset by a valuation allowance.
Net Loss
As a result of the above, the Company recorded net losses of $191,410 and $937,483 for the three and six months ended September 30, 2018 as compared to net losses before taxes of $2,920,589 and $3,206,680 for the three and six months ended September 30, 2017.
Liquidity and Capital Resources
At September 30, 2018, the Company had net negative working capital of $2,110,997 as compared to negative working capital of $1,335,879 at March 31, 2018. This change is primarily the result of lower accounts receivable and inventories.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations (continued).
Liquidity and Capital Resources (continued)
These consolidated financial statements have been prepared in conformity with GAAP, which contemplates continuation of the Company as a going concern. As reflected in the accompanying financial statements, for the year ended March 31, 2018, the Company incurred a net loss of $4,322,311, and also incurred a net loss of $937,483 for the six months ended September 30, 2018. As discussed in Note 14 to the Notes to the Condensed Consolidated Financial Statements, the Company has recorded estimated damages to date of $5,059,960, including interest and additional fees, as a result of the jury verdict associated with the Aeroflex litigation. The Company’s line of credit agreement expired on Mach 31, 2018. On August 29, 2018, the Company entered a Loan Modification Agreement (the “Agreement”) with the bank. The Company had been working with the bank and had paid $100,000 to lower the outstanding balance to $900,000 at the signing of the Agreement (see Note 9 to Notes to the Condensed Consolidated Financial Statements). The Company believes it has sufficient financing in place to fund its plans for the next twelve months due in part to recent large orders it has received that should return the Company to profitability. However, the Company cannot predict the timing or the outcome of the appeal for the Aeroflex Litigation. The pending judgment raises substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued.
Regarding the Aeroflex litigation, the jury found no misappropriation of Aeroflex trade secrets but it did rule that the Company tortiously interfered with a prospective business opportunity and awarded damages. The jury also ruled that Tel tortiously interfered with Aeroflex’s non-disclosure agreements with two former Aeroflex employees. The jury also found that the former Aeroflex employees breached their non-disclosure agreements with Aeroflex. The Court conducted further hearings on the Company’s post-trial motions which sought to reduce the damages award of $2.8 million, as well as the punitive damages claim. The Court denied the Company’s motions and awarded Aeroflex an additional $2.1 million of punitive damages. The Company filed motions in January 2018 for the Court to reconsider the amount of damages on the grounds that they are duplicative and not legally supportable. A hearing on this motion was held. The Judge rejected all of our arguments and declined to order a new trial. We filed the appeal document in May 2018. The Company has posted a $2 million bond. This $2 million bond amount will remain in place during the appeal process (See Notes 5 and 14). The Company believes it has solid grounds to appeal this verdict. The appeal process is anticipated to take several years to complete.
The financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities and commitments in the normal course of business. The ability of the Company to continue as a going concern is dependent upon its ability to achieve profitable operations and/or raise additional capital to support the appeal process or pay any final damages amount. In November 2017, the Company entered into a subscription agreement pursuant to which the investor purchased an aggregate of 500,000 shares of the Company’s Series A Preferred Stock for an aggregate amount of $3 million (See Note 13 to the Notes to the Condensed Financial Statements). These funds were used to finance an appeal bond and provide funds for operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. In October 2018, the Company entered into a subscription agreement pursuant to which an investor purchased 166,667 shares of the Company’s Series B Preferred Stock for $1 million. These funds are being used for working capital purposes to support the orders received and expected in the near term.
During the six months ended September 30, 2018, the Company’s cash balance decreased by $29,369 to $278,443. The Company’s principal sources and uses of funds were as follows:
Cash used in operating activities. For the six months ended September 30, 2018, the Company used $20,062 in cash for operations as compared to using $684,861 in cash for operations for the six months ended September 30, 2017. This decrease in cash used for operations is primarily the result of decreases in inventories, an increase in deferred revenues offset mostly a decrease in accounts payable and accrued expenses.
Cash used in investing activities. For the six months ended September 30, 2018, the Company used $-0- of its cash for investment activities, as compared to $53,402 for the six months ended September 30, 2017 as a result of an decrease in the purchase of capital equipment.
Cash (used in) provided by financing activities. For the six months ended September 30, 2018, the Company used $9,307 in cash for financing activities as compared to providing $580,625 for the six months ended September 30, 2017 primarily as a result of the no borrowings from the line of credit for the current fiscal year.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations (continued).
Liquidity and Capital Resources (continued)
On March 21, 2016, the Company entered into a line of credit agreement with Bank of America, which expired March 31, 2017. In March 2017, the line of credit was renewed and the expiration dateCompany extended until March 31, 2018. The new line providesprovided a revolving credit facility with borrowing capacity of up to $1,000,000. There are no covenants or borrowing base calculations associated with this line of credit. Interest on any outstanding balances is payable monthly at an annual interest rate equal to the LIBOR (London Interbank Offered Rates) Daily Floating plus 3.75 percentage points. The Company’s interest rate was 4.985% at September 30, 2017. The line is collateralized by substantially all of the assets of the Company. During the six months ended September 30, 2017, the Company borrowed $800,000 from this line of credit. As of September 30, 2017 and March 31, 2017, the outstanding balances were $1,000,000 and $200,000, respectively. As of September 30, 2017 the remaining availability under this line was $-0-.
1) | The Company to make an additional principal payment of $50,000 by October 1, 2018. (The Company made this payment.) |
2) | Borrowing base calculation tied to accounts receivable and inventories. |
3) | The Agreement expires May 31, 2019. |
4) | Interest on any outstanding balances is payable monthly at an annual interest rate equal to the LIBOR (London Interbank Offered Rates) Daily Floating plus 3.75 percentage points. The Company’s interest rate was 5.915% at September 30, 2018. |
5) | The line is collateralized by substantially all of the assets of the Company. |
6) | The Company will make principal payments of $5,000 per month from September 30, 2018 through November 30, 2018 and principal payments of $10,000 per month from December 31, 2018 to May 31, 2019. |
7) | Beginning with the fiscal year ended March 31, 2019, the Company must maintain a debt service coverage ratio. |
Currently, the Company has no material future capital expenditure requirements.
There was no significant impact on the Company’s operations as a result of inflation for the six months ended September 30, 2017.
These financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2017,2018, filed with the SEC on July 14, 201716, 2018 (the “Annual Report”).
Off-Balance Sheet Arrangements
As of September 30, 2017,2018, the Company had no material off-balance sheet arrangements.
Critical Accounting Policies
Our critical accounting policies are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report. There have been no changes in our critical accounting policies. Our significant accounting policies are described in our notes to the 20172018 consolidated financial statements included in our Annual Report.
We do not hold any derivative instruments and do not engage in any hedging activities.
(a) Evaluation of Disclosure Controls and Procedures
The Company, including its principal executive officer and principal financial officer, conducted an evaluation of the effectiveness of the design and operation of its disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”) as of the end of the period covered by this report (the “Evaluation Date”). Based upon the evaluation, our principal executive officer and principal financial officer concluded as of the Evaluation Date that our disclosure controls and procedures were effective. Disclosure controls are controls and procedures designed to reasonably ensure that information required to be disclosed in our reports filed under the Exchange Act, such as this report, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls include controls and procedures designed to reasonably ensure that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.
(b) Changes in Internal Control over Financial Reporting
The Company, including its principal executive officer and principal accounting officer, reviewed the Company’s internal control over financial reporting, pursuant to Rule 13(a)-15(e) under the Exchange Act and concluded that there was no change in the Company’s internal control over financial reporting during the Company’s most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II – OTHER INFORMATION
On March 24, 2009, Aeroflex Wichita, Inc. (“Aeroflex”) filed a petition against the Company and two of its employees in the District Court located in Sedgwick County, Kansas, Case No. 09 CV 1141 (the “Aeroflex Action”), alleging that the Company and its two employees misappropriated Aeroflex’s proprietary technology in connection with the Company winning a substantial contract from the U.S. Army, to develop new Mode-5 radar test sets and kits to upgrade the existing TS-4530 radar test sets to Mode 5 (the “Award”). Aeroflex’s petition, seeking injunctive relief and damages, alleges that in connection with the Award, the Company and its named employees misappropriated Aeroflex’s trade secrets; tortiously interfered with Aeroflex’s business relationship; conspired to harm Aeroflex and tortiously interfered with Aeroflex’s contract. The central basis of all the claims in the Aeroflex Action is that the Company misappropriated and used Aeroflex proprietary technology and confidential information in winning the Award. In February 2009, subsequent to the Company winning the Award, Aeroflex filed a protest of the Award with the Government Accounting Office (“GAO”).
In its protest, Aeroflex alleged, inter alia, that the Company used Aeroflex’s proprietary technology in order to win the Award, the same material allegations as were later alleged in the Aeroflex Action. On or about March 17, 2009, the U.S. Army Contracts Attorney and the U.S. Army Contracting Officer each filed a statement with the GAO, expressly rejecting Aeroflex’s allegations that the Company used or infringed on Aeroflex’s proprietary technology in winning the Award, and concluding that the Company had used only its own proprietary technology. On April 6, 2009, Aeroflex withdrew its protest.
In December 2009, the Kansas District Court dismissed the Aeroflex Action on jurisdiction grounds. Aeroflex appealed this decision. In May 2012, the Kansas Supreme Court reversed the decision and remanded the Aeroflex Action to the Kansas District Court for further proceedings.
On May 23, 2016, the Company filed a motion for summary judgment based on Aeroflex’s lack of jurisdictional standing to bring the case. The motion asserts that Aeroflex does not own the intellectual property at issue since it is a bare licensee of Northrop Grumman. Northrop Grumman has declined to join this suit as plaintiff. Aeroflex lacks standing to sue alone. Also, the motion raises the fact that Aeroflex allowed the license to expire,expire. Aeroflex’s claims are either moot or Aeroflex lacks standing to sue for damages alleged to have accrued after the license ended in 2011. The motion for summary judgment was denied.
The Aeroflex trial on remand in the Kansas District Court began in March 2017. After a six-weeknine-week trial, the jury rendered its verdict. The jury found no misappropriation of Aeroflex trade secrets but it did rule that the Company tortiously interfered with a prospective business opportunity and awarded damages of $1.3 million for lost profits. The jury also ruled that Tel tortiously interfered with Aeroflex’s non-disclosure agreements with two former Aeroflex employees and awarded damages of $1.5 million for lost profits, resulting in total damages against the Company of $2.8 million. The jury also found that the former Aeroflex employees breached their non-disclosure agreements with Aeroflex and awarded damages against these two individuals totaling $525,000. The jury also decided that punitive damages should be allowed against the Company.
Following the verdict, the Company filed a motion for judgment as a matter of law. In the motion, the Company renewed its motion for judgment on Aeroflex’s tortious interference with prospective business opportunity claim arguing that such claim is barred by the statute of limitations. Alternatively, the motion asserts there is insufficient evidence supporting the lost profit award on that claim. Additionally, the motion for judgment addresses inconsistency between the awards against the former Aeroflex employees for breach of the non-disclosure agreements and the award against the Company for interfering with those agreements. Alternatively, the motion asserts there is insufficient evidence supporting the lost profit award on that claim.
During July 2017, the Court heard the Company’s motion for judgment as well as conducting a hearing as to the amount of a punitive damages award. Kansas statutes limit punitive damages to a maximum of $5 million.
Aeroflex submitted a motion to the Court requesting that the judge award punitive damages at the maximum $5 million amount. In Kansas, punitive damages are awarded to “punish the wrongdoer for his malicious, vindictive or willful and wanton invasion of another’s rights, with the ultimate purpose being to restrain and deter others from the commission of similar wrongdoings.” Importantly, Kansas courts have ruled that the purpose of punitive damages “is to sting, not to kill”. The Court will also take into consideration the Company’s financial condition in setting the amount of punitive damages
The Company filed motions in January 2018 for the court, and we have filed a motion withCourt to reconsider the courtamount of damages on the grounds that these changesthey are duplicative and not supported by Kansas Law.
Item 1. Legal Proceedings (continued).
On July 5, 2018, Plaintiff Aeroflex Wichita, Inc. filed a Notice of Cross-Appeal which is contingent in nature in that it seeks a review of all adverse rulings relating to its Motion for Relief and Sanctions; Defendants’ Motions for Summary Judgment; determining that certain matters were not trade secrets; Defendants’ joint and several liability; preemption under the Company signedKansas Uniform Trade Secrets Act; motions in limine; motions for judgment as a subscription agreementmatter of law; jury instructions; admission of evidence over its objections; and all other ruling adverse to it only if the court reverses the jury verdict and judgment. Aeroflex Wichita also reserved the right to ask the reviewing court to order a new trial either on damages alone or on liability for all claims. This reservation of rights is also contingent upon a finding of the appellate court which would reverse the jury verdict and judgment. Aeroflex Wichita filed its Docketing Statement the same day.
On July 11, 2018, the Court of Appeals entered an Order of Referral to Mediation and Order to Stay. The Company’s case was selected to participate in which the Company received $3 million for Series A Convertible Preferred Stock (See Note 16Kansas Court of Appeals Appellate Mediation pilot program. Participation in the program is voluntary, either party may opt out of participation. The order staying the case was lifted because Aeroflex Wichita, Inc. opted out, and as a result the appeal will proceed under normal procedures.The appeal process is anticipated to the Notestake several years to the Condensed Financial Statements). These funds will be used to finance an appeal and provide funds for operations.
Other than the matters outlined above, we are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of executive officers of our Company, threatened against or affecting our Company, or our common stock in which an adverse decision could have a material effect.
We believe there are no changes that constitute material changes from the risk factors previously disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2017,2018, filed with the SEC on July 14, 2017.
There were no unregistered sales of the Company’s equity securities during the quarter ended September 30, 2017 other than those previously reported in a Current Report on Form 8-K.
There has been no default in the payment of principal, interest, sinking or purchase fund installment, or any other material default, with respect to any indebtedness of the Company.
Not applicable.
There is no other information required to be disclosed under this item which was not previously disclosed.
Exhibit No. | Description | |
31.1 | ||
31.2 | ||
32.1 | ||
32.2 | ||
101.INS | XBRL Instance Document* | |
101.SCH | Taxonomy Extension Schema Document* | |
101.CAL | Taxonomy Extension Calculation Linkbase Document* | |
101.DEF | Taxonomy Extension Definition Linkbase Document* | |
101.LAB | Taxonomy Extension Label Linkbase Document* | |
101.PRE | Taxonomy Extension Presentation Linkbase Document* |
* Filed herewith
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
TEL-INSTRUMENT ELECTRONICS CORP. | ||||
Date: November | By: | /s/ Jeffrey C. O’Hara | ||
Name: Jeffrey C. O’Hara | ||||
Title: Chief Executive Officer Principal Executive Officer | ||||
Date: November | By: | /s/ Joseph P. Macaluso | ||
Name: Joseph P. Macaluso | ||||
Title: Principal Financial Officer Principal Accounting Officer |